Search Results
Psychedelic-assisted treatments for psychiatric ailments look promising for appropriately screened samples ( Ilingworth et al., 2021 ; Luoma, Chwyl, Bathje, Davis, & Lancelotta, 2020 ; Romeo, Karila, Martelli, & Benyamina, 2020 ; Zeifman et
Introduction With the continuing development of the “psychedelic renaissance” of research on the therapeutic and spiritual value of psychedelic compounds and particularly with the appearance of Michael Pollan's New York Times bestseller on
quality patient care. With the recent resurgence of psychedelics as a ‘re-emerging therapeutic paradigm’ ( Tupper, 2015 ), showing promising results in clinical research ( Elsey, 2017 ; Sessa, 2012 ), by successfully addressing symptoms of psychological
Psychedelic drugs such as psilocybin and lysergic acid diethylamide (LSD) as well as related compounds (e.g., 3,4-Methylenedioxymethamphetamine; MDMA) have preliminarily demonstrated a high level of safety and efficacy for treating psychiatric
; Guerrero et al., 2017 ; Hewell, Vasquez, & Rivkin, 2017 ; Lagisetty, Ross, Bohnert, Clay, & Maust, 2019 ; Sharma et al., 2017 ; Truong et al., 2019 ). Psilocybin is a “classic psychedelic” that exerts its psychological effects through 5-HT2A
Excitement is growing for novel mental health treatments emerging out of recent psychedelic research following a decades-long prohibition due to the Controlled Substances Act of 1971. Preliminary safety and efficacy of psychedelic-assisted therapy
Psychedelics and critical theory
A response to Hauskeller's individualization and alienation in psychedelic psychotherapy
Commentary on : Hauskeller , C. ( 2022 ). Individualization and alienation in psychedelic psychotherapy . In C. Hauskeller , & P. Sjöstedt-Hughes (Eds.), Philosophy and psychedelics: Frameworks for exceptional experience ( pp. 107
Introduction As Ido Hartogsohn (2017 , p. 1) so aptly writes, “the question of extra-pharmacological variables is becoming increasingly urgent.” Hartogsohn is referring here to the framework of set and setting, which has been central to psychedelic
, Lancelotta, Barsuglia, & Griffiths, 2019 ). Similar to other classic psychedelic substances [e.g., psilocybin, lysergic acid diethylmide (LSD), and dimethyltryptamine (DMT)], 5-MeO-DMT acts as an agonist at 5-HT 1A and 5-HT 2A receptors and is a full
Introduction Etymologically, the term ‘psychedelic’ means ‘mind-revealing’ and, in the context of this paper, denotes a class of drugs whose common phenomenology exhibits a wide spectrum of subjective effects and intensity, ranging from mild
